Evgen Pharma (GB:TCF) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
James Robert Kight has increased his stake in Theracryf PLC, with the acquisition of additional voting rights, now holding a total of 8.09647% or 34,600,000 voting rights. The notification was filed on July 17, 2024, after the threshold was crossed on the previous day. This move might suggest a growing confidence in the company’s prospects, which could interest investors tracking shareholder activity for investment insights.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.
